Search results
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
AstraZeneca develops, manufactures and sells pharmaceutical and biotechnology products to treat disorders in the oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation areas.
We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
AstraZeneca Pharma India Limited (AZPIL) is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK.
5 days ago · Apart from being a hub for technology as well as research and development, AstraZeneca markets and distributes its innovative portfolio in specialist disease areas including oncology, cardio-vascular, respiratory and rare disease. The investment marks AstraZeneca's 45th year in India.
AstraZeneca India is a dedicated biopharmaceutical company discovering and developing innovative medicines for life-changing diseases. Learn more about our India chapter and our global edge, here.
Our medicines are approved in individual countries for specific uses and the information we provide for patients is governed by local regulations. In some cases, health care professionals and patients can visit local AstraZeneca websites to find out more about our medicines.
1 day ago · AstraZeneca, British-Swedish biopharmaceutical company with medicine sales in more than 130 countries, making it one of the largest drug companies in the world. AstraZeneca’s main research and development areas include oncology, rare diseases, and biopharmaceutical intervention, and it has numerous.
Jul 1, 2024 · AstraZeneca said on Monday that the European Union drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention drug, sipavibart, for an accelerated ...
5 days ago · AstraZeneca: With the highly skilled roles to be brought in by 2025, the expanded GITC will propel the company's vision to leverage technologies such as enterprise platforms, artificial ...
